NCT05541939View on ClinicalTrials.gov

Effect of Mizagliflozin on Postprandial Glucose and Insulin in Post-Bariatric Hypoglycemia Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

September 13, 2022

Primary Completion Date

February 17, 2023

Study Completion Date

February 17, 2023

Conditions
Postbariatric Hypoglycemia
Interventions
DRUG

Mizagliflozin

Encapsulated or Liquid Formulation

Trial Locations (2)

80045

University of Colorado / Anschutz Medical Campus, Aurora

94304

Stanford, Palo Alto

All Listed Sponsors
lead

Vogenx, Inc.

INDUSTRY